Global Polyvalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

According to our (Global Info Research) latest study, the global Polyvalent Antivenom market size was valued at USD 591.6 million in 2022 and is forecast to a readjusted size of USD 779.6 million by 2029 with a CAGR of 4.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

This report is a detailed and comprehensive analysis for global Polyvalent Antivenom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Polyvalent Antivenom market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Polyvalent Antivenom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Polyvalent Antivenom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Polyvalent Antivenom market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Polyvalent Antivenom
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Polyvalent Antivenom market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Polyvalent Antivenom market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Antiviral Toxin-based Antivenom
    Anti - Neurotoxic Antivenom
    Anti - Mixed Venom Antivenom

Market segment by Application
    Non-profit Institutions
    Hospitals and Clinic

Major players covered
    CSL
    Merck
    BTG
    Pfizer
    Haffkine Bio-Pharmaceutical
    Rare Disease Therapeutics
    Flynn Pharma
    Vins Bioproducts
    Bharat Serums and Vaccines
    Serum Biotech
    MicroPharm

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polyvalent Antivenom product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Polyvalent Antivenom, with price, sales, revenue and global market share of Polyvalent Antivenom from 2018 to 2023.
Chapter 3, the Polyvalent Antivenom competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polyvalent Antivenom breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Polyvalent Antivenom market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Polyvalent Antivenom.
Chapter 14 and 15, to describe Polyvalent Antivenom sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Polyvalent Antivenom
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Polyvalent Antivenom Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Antiviral Toxin-based Antivenom
        1.3.3 Anti - Neurotoxic Antivenom
        1.3.4 Anti - Mixed Venom Antivenom
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Polyvalent Antivenom Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Non-profit Institutions
        1.4.3 Hospitals and Clinic
    1.5 Global Polyvalent Antivenom Market Size & Forecast
        1.5.1 Global Polyvalent Antivenom Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Polyvalent Antivenom Sales Quantity (2018-2029)
        1.5.3 Global Polyvalent Antivenom Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Polyvalent Antivenom Product and Services
        2.1.4 CSL Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 CSL Recent Developments/Updates
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Polyvalent Antivenom Product and Services
        2.2.4 Merck Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck Recent Developments/Updates
    2.3 BTG
        2.3.1 BTG Details
        2.3.2 BTG Major Business
        2.3.3 BTG Polyvalent Antivenom Product and Services
        2.3.4 BTG Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 BTG Recent Developments/Updates
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Polyvalent Antivenom Product and Services
        2.4.4 Pfizer Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Pfizer Recent Developments/Updates
    2.5 Haffkine Bio-Pharmaceutical
        2.5.1 Haffkine Bio-Pharmaceutical Details
        2.5.2 Haffkine Bio-Pharmaceutical Major Business
        2.5.3 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product and Services
        2.5.4 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
    2.6 Rare Disease Therapeutics
        2.6.1 Rare Disease Therapeutics Details
        2.6.2 Rare Disease Therapeutics Major Business
        2.6.3 Rare Disease Therapeutics Polyvalent Antivenom Product and Services
        2.6.4 Rare Disease Therapeutics Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Rare Disease Therapeutics Recent Developments/Updates
    2.7 Flynn Pharma
        2.7.1 Flynn Pharma Details
        2.7.2 Flynn Pharma Major Business
        2.7.3 Flynn Pharma Polyvalent Antivenom Product and Services
        2.7.4 Flynn Pharma Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Flynn Pharma Recent Developments/Updates
    2.8 Vins Bioproducts
        2.8.1 Vins Bioproducts Details
        2.8.2 Vins Bioproducts Major Business
        2.8.3 Vins Bioproducts Polyvalent Antivenom Product and Services
        2.8.4 Vins Bioproducts Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Vins Bioproducts Recent Developments/Updates
    2.9 Bharat Serums and Vaccines
        2.9.1 Bharat Serums and Vaccines Details
        2.9.2 Bharat Serums and Vaccines Major Business
        2.9.3 Bharat Serums and Vaccines Polyvalent Antivenom Product and Services
        2.9.4 Bharat Serums and Vaccines Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bharat Serums and Vaccines Recent Developments/Updates
    2.10 Serum Biotech
        2.10.1 Serum Biotech Details
        2.10.2 Serum Biotech Major Business
        2.10.3 Serum Biotech Polyvalent Antivenom Product and Services
        2.10.4 Serum Biotech Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Serum Biotech Recent Developments/Updates
    2.11 MicroPharm
        2.11.1 MicroPharm Details
        2.11.2 MicroPharm Major Business
        2.11.3 MicroPharm Polyvalent Antivenom Product and Services
        2.11.4 MicroPharm Polyvalent Antivenom Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 MicroPharm Recent Developments/Updates

3 Competitive Environment: Polyvalent Antivenom by Manufacturer
    3.1 Global Polyvalent Antivenom Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Polyvalent Antivenom Revenue by Manufacturer (2018-2023)
    3.3 Global Polyvalent Antivenom Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Polyvalent Antivenom by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Polyvalent Antivenom Manufacturer Market Share in 2022
        3.4.2 Top 6 Polyvalent Antivenom Manufacturer Market Share in 2022
    3.5 Polyvalent Antivenom Market: Overall Company Footprint Analysis
        3.5.1 Polyvalent Antivenom Market: Region Footprint
        3.5.2 Polyvalent Antivenom Market: Company Product Type Footprint
        3.5.3 Polyvalent Antivenom Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Polyvalent Antivenom Market Size by Region
        4.1.1 Global Polyvalent Antivenom Sales Quantity by Region (2018-2029)
        4.1.2 Global Polyvalent Antivenom Consumption Value by Region (2018-2029)
        4.1.3 Global Polyvalent Antivenom Average Price by Region (2018-2029)
    4.2 North America Polyvalent Antivenom Consumption Value (2018-2029)
    4.3 Europe Polyvalent Antivenom Consumption Value (2018-2029)
    4.4 Asia-Pacific Polyvalent Antivenom Consumption Value (2018-2029)
    4.5 South America Polyvalent Antivenom Consumption Value (2018-2029)
    4.6 Middle East and Africa Polyvalent Antivenom Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    5.2 Global Polyvalent Antivenom Consumption Value by Type (2018-2029)
    5.3 Global Polyvalent Antivenom Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    6.2 Global Polyvalent Antivenom Consumption Value by Application (2018-2029)
    6.3 Global Polyvalent Antivenom Average Price by Application (2018-2029)

7 North America
    7.1 North America Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    7.2 North America Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    7.3 North America Polyvalent Antivenom Market Size by Country
        7.3.1 North America Polyvalent Antivenom Sales Quantity by Country (2018-2029)
        7.3.2 North America Polyvalent Antivenom Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    8.2 Europe Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    8.3 Europe Polyvalent Antivenom Market Size by Country
        8.3.1 Europe Polyvalent Antivenom Sales Quantity by Country (2018-2029)
        8.3.2 Europe Polyvalent Antivenom Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Polyvalent Antivenom Market Size by Region
        9.3.1 Asia-Pacific Polyvalent Antivenom Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Polyvalent Antivenom Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    10.2 South America Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    10.3 South America Polyvalent Antivenom Market Size by Country
        10.3.1 South America Polyvalent Antivenom Sales Quantity by Country (2018-2029)
        10.3.2 South America Polyvalent Antivenom Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Polyvalent Antivenom Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Polyvalent Antivenom Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Polyvalent Antivenom Market Size by Country
        11.3.1 Middle East & Africa Polyvalent Antivenom Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Polyvalent Antivenom Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Polyvalent Antivenom Market Drivers
    12.2 Polyvalent Antivenom Market Restraints
    12.3 Polyvalent Antivenom Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Polyvalent Antivenom and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Polyvalent Antivenom
    13.3 Polyvalent Antivenom Production Process
    13.4 Polyvalent Antivenom Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Polyvalent Antivenom Typical Distributors
    14.3 Polyvalent Antivenom Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Polyvalent Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Polyvalent Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Polyvalent Antivenom Product and Services
    Table 6. CSL Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. CSL Recent Developments/Updates
    Table 8. Merck Basic Information, Manufacturing Base and Competitors
    Table 9. Merck Major Business
    Table 10. Merck Polyvalent Antivenom Product and Services
    Table 11. Merck Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Merck Recent Developments/Updates
    Table 13. BTG Basic Information, Manufacturing Base and Competitors
    Table 14. BTG Major Business
    Table 15. BTG Polyvalent Antivenom Product and Services
    Table 16. BTG Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. BTG Recent Developments/Updates
    Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer Polyvalent Antivenom Product and Services
    Table 21. Pfizer Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Pfizer Recent Developments/Updates
    Table 23. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 24. Haffkine Bio-Pharmaceutical Major Business
    Table 25. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product and Services
    Table 26. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Haffkine Bio-Pharmaceutical Recent Developments/Updates
    Table 28. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 29. Rare Disease Therapeutics Major Business
    Table 30. Rare Disease Therapeutics Polyvalent Antivenom Product and Services
    Table 31. Rare Disease Therapeutics Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Rare Disease Therapeutics Recent Developments/Updates
    Table 33. Flynn Pharma Basic Information, Manufacturing Base and Competitors
    Table 34. Flynn Pharma Major Business
    Table 35. Flynn Pharma Polyvalent Antivenom Product and Services
    Table 36. Flynn Pharma Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Flynn Pharma Recent Developments/Updates
    Table 38. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
    Table 39. Vins Bioproducts Major Business
    Table 40. Vins Bioproducts Polyvalent Antivenom Product and Services
    Table 41. Vins Bioproducts Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Vins Bioproducts Recent Developments/Updates
    Table 43. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
    Table 44. Bharat Serums and Vaccines Major Business
    Table 45. Bharat Serums and Vaccines Polyvalent Antivenom Product and Services
    Table 46. Bharat Serums and Vaccines Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Bharat Serums and Vaccines Recent Developments/Updates
    Table 48. Serum Biotech Basic Information, Manufacturing Base and Competitors
    Table 49. Serum Biotech Major Business
    Table 50. Serum Biotech Polyvalent Antivenom Product and Services
    Table 51. Serum Biotech Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Serum Biotech Recent Developments/Updates
    Table 53. MicroPharm Basic Information, Manufacturing Base and Competitors
    Table 54. MicroPharm Major Business
    Table 55. MicroPharm Polyvalent Antivenom Product and Services
    Table 56. MicroPharm Polyvalent Antivenom Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. MicroPharm Recent Developments/Updates
    Table 58. Global Polyvalent Antivenom Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 59. Global Polyvalent Antivenom Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 60. Global Polyvalent Antivenom Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 61. Market Position of Manufacturers in Polyvalent Antivenom, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 62. Head Office and Polyvalent Antivenom Production Site of Key Manufacturer
    Table 63. Polyvalent Antivenom Market: Company Product Type Footprint
    Table 64. Polyvalent Antivenom Market: Company Product Application Footprint
    Table 65. Polyvalent Antivenom New Market Entrants and Barriers to Market Entry
    Table 66. Polyvalent Antivenom Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Polyvalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 68. Global Polyvalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 69. Global Polyvalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 70. Global Polyvalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 71. Global Polyvalent Antivenom Average Price by Region (2018-2023) & (US$/Unit)
    Table 72. Global Polyvalent Antivenom Average Price by Region (2024-2029) & (US$/Unit)
    Table 73. Global Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 74. Global Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 75. Global Polyvalent Antivenom Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Global Polyvalent Antivenom Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Global Polyvalent Antivenom Average Price by Type (2018-2023) & (US$/Unit)
    Table 78. Global Polyvalent Antivenom Average Price by Type (2024-2029) & (US$/Unit)
    Table 79. Global Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 80. Global Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 81. Global Polyvalent Antivenom Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. Global Polyvalent Antivenom Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. Global Polyvalent Antivenom Average Price by Application (2018-2023) & (US$/Unit)
    Table 84. Global Polyvalent Antivenom Average Price by Application (2024-2029) & (US$/Unit)
    Table 85. North America Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 86. North America Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 87. North America Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 88. North America Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 89. North America Polyvalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 90. North America Polyvalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 91. North America Polyvalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. North America Polyvalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Europe Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 94. Europe Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 95. Europe Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 96. Europe Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 97. Europe Polyvalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 98. Europe Polyvalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 99. Europe Polyvalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Polyvalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 102. Asia-Pacific Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 103. Asia-Pacific Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 104. Asia-Pacific Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 105. Asia-Pacific Polyvalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 106. Asia-Pacific Polyvalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 107. Asia-Pacific Polyvalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 108. Asia-Pacific Polyvalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 109. South America Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 110. South America Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 111. South America Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 112. South America Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 113. South America Polyvalent Antivenom Sales Quantity by Country (2018-2023) & (K Units)
    Table 114. South America Polyvalent Antivenom Sales Quantity by Country (2024-2029) & (K Units)
    Table 115. South America Polyvalent Antivenom Consumption Value by Country (2018-2023) & (USD Million)
    Table 116. South America Polyvalent Antivenom Consumption Value by Country (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Polyvalent Antivenom Sales Quantity by Type (2018-2023) & (K Units)
    Table 118. Middle East & Africa Polyvalent Antivenom Sales Quantity by Type (2024-2029) & (K Units)
    Table 119. Middle East & Africa Polyvalent Antivenom Sales Quantity by Application (2018-2023) & (K Units)
    Table 120. Middle East & Africa Polyvalent Antivenom Sales Quantity by Application (2024-2029) & (K Units)
    Table 121. Middle East & Africa Polyvalent Antivenom Sales Quantity by Region (2018-2023) & (K Units)
    Table 122. Middle East & Africa Polyvalent Antivenom Sales Quantity by Region (2024-2029) & (K Units)
    Table 123. Middle East & Africa Polyvalent Antivenom Consumption Value by Region (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Polyvalent Antivenom Consumption Value by Region (2024-2029) & (USD Million)
    Table 125. Polyvalent Antivenom Raw Material
    Table 126. Key Manufacturers of Polyvalent Antivenom Raw Materials
    Table 127. Polyvalent Antivenom Typical Distributors
    Table 128. Polyvalent Antivenom Typical Customers
List of Figures
    Figure 1. Polyvalent Antivenom Picture
    Figure 2. Global Polyvalent Antivenom Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Polyvalent Antivenom Consumption Value Market Share by Type in 2022
    Figure 4. Antiviral Toxin-based Antivenom Examples
    Figure 5. Anti - Neurotoxic Antivenom Examples
    Figure 6. Anti - Mixed Venom Antivenom Examples
    Figure 7. Global Polyvalent Antivenom Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Polyvalent Antivenom Consumption Value Market Share by Application in 2022
    Figure 9. Non-profit Institutions Examples
    Figure 10. Hospitals and Clinic Examples
    Figure 11. Global Polyvalent Antivenom Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Polyvalent Antivenom Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Polyvalent Antivenom Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Polyvalent Antivenom Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Polyvalent Antivenom Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Polyvalent Antivenom Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Polyvalent Antivenom by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Polyvalent Antivenom Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Polyvalent Antivenom Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Polyvalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Polyvalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Polyvalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Polyvalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Polyvalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Polyvalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Polyvalent Antivenom Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Polyvalent Antivenom Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Polyvalent Antivenom Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Polyvalent Antivenom Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Polyvalent Antivenom Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Polyvalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Polyvalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Polyvalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Polyvalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Polyvalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Polyvalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Polyvalent Antivenom Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Polyvalent Antivenom Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Polyvalent Antivenom Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Polyvalent Antivenom Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Polyvalent Antivenom Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Polyvalent Antivenom Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Polyvalent Antivenom Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Polyvalent Antivenom Market Drivers
    Figure 74. Polyvalent Antivenom Market Restraints
    Figure 75. Polyvalent Antivenom Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Polyvalent Antivenom in 2022
    Figure 78. Manufacturing Process Analysis of Polyvalent Antivenom
    Figure 79. Polyvalent Antivenom Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm

Related Reports

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2023-2029

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Polyvalent Antivenom market size is expected to reach $ 779.6 million by 2029, rising at a market growth of 4.0% CAGR during the forecast period (2023-2029).

Global Polyvalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Polyvalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Polyvalent Antivenom market size was valued at USD 591.6 million in 2023 and is forecast to a readjusted size of USD 779.6 million by 2030 with a CAGR of 4.0% during review period.

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2024-2030

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Polyvalent Antivenom market size is expected to reach $ 779.6 million by 2030, rising at a market growth of 4.0% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>